In the “ferroptosis” pathway, four genes (CP, SLC3A2, SLC11A2, and ACSL5) had lower expression in NASH and two genes (ATG7 and ACSL4) had higher expression. Here, ACSL5 is linked to metabolic dysfunction-associated steatohepatitis.